Saturday, November 16, 2024
- Advertisement -spot_img

TAG

CAMP4

CAMP4 Therapeutics seeks up to $283 million valuation in US IPO

(Reuters) - CAMP4 Therapeutics, a biopharmaceutical company backed by healthcare giant Kaiser Permanente, said on Monday it was targeting a valuation of up to...

Latest news

- Advertisement -spot_img